Susquehanna International Group’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.21M Sell
70,100
-59,700
-46% -$1.88M ﹤0.01% 5953
2025
Q4
$3.82M Buy
129,800
+5,200
+4% +$144K ﹤0.01% 4473
2025
Q3
$3.15M Buy
124,600
+31,700
+34% +$773K ﹤0.01% 4888
2025
Q2
$2.23M Buy
92,900
+61,100
+192% +$1.42M ﹤0.01% 5563
2025
Q1
$728K Sell
31,800
-96,300
-75% -$2.32M ﹤0.01% 8050
2024
Q4
$3.24M Sell
128,100
-242,600
-65% -$6.15M ﹤0.01% 4329
2024
Q3
$9.24M Buy
370,700
+247,800
+202% +$7.34M ﹤0.01% 2722
2024
Q2
$3.64M Buy
122,900
+11,100
+10% +$308K ﹤0.01% 3963
2024
Q1
$3.37M Buy
+111,800
New +$3.1M ﹤0.01% 4287

Other funds holding RTO

Susquehanna International Group's RTO Position: Q2 2025 in Review

Susquehanna International Group sold out of Rentokil (RTO) in Q2 2025, closing a stake of 28,470 shares — an estimated $660K sold.

Susquehanna International Group first reported a position in RTO in Q4 2022 and held it in 4 quarters. The position peaked at $5.82M in Q4 2022. 206 funds tracked by Wall St. Rank hold RTO as of Q2 2025.

  • Susquehanna International Group reported no remaining Rentokil position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 28,470 Rentokil shares in Q2 2025, an estimated $660K.
  • Susquehanna International Group first reported a position in Rentokil in Q4 2022 and held it in 4 quarters.
  • Susquehanna International Group's Rentokil position peaked at $5.82M in Q4 2022.
  • 206 funds tracked by Wall St. Rank held Rentokil as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.